Abstract
Objective: The Study entitled “Prevalence of Obesity and Metabolic Syndrome among Adults in Tertiary Care Hospitals of Coastal Andhra” was designed to assess the awareness of Obesity and Metabolic syndrome reporting at a reputed pharmacy institute in Andhra Pradesh, India, and also to evaluate the impact of an educational intervention carried out in this study. A suitable collection data form, attitude survey questionnaire was designed and validated by pilot study and the study was conducted among inpatients and out patients of hospitals.
Method: This cross- sectional study, of 6 month duration included a total of 353 participants. An interactive educational intervention was designed for all participants in hospital. The impact of effectiveness of educational intervention among the patients was evaluated by means of questionnaire survey. The paired t- test in SASversion8 was used for statistical calculation. In our study a total of 353 participants responded and involved in the collection data form and questionnaire survey. Participants involved in the study were 196 male and 157 female patients in hospitals. The overall response rates between collection data and questionnaire was statistically significant (P< 0.045) which shows effectiveness of educational intervention for improving awareness of obesity and metabolic syndrome among the adult participants.
Conclusion: The study concluded that imparting the awareness of obesity and metabolic syndrome among the adult patients by means of continuous educational intervention would bring up updated knowledge about of cardiovascular diseases and other causing diseases.
References
Kaur J (2014). "A comprehensive review on metabolic syndrome". Cardiology research practice.” 2014;(9):1- 21
Ya-Chun Hsiao, Kuangte Wang, and Ming-Jong Bair. “Prevalence of Obesity and Metabolic Syndrome in Aboriginals in Southeastern Taiwan–A Hospital-based Study.”J Endocrinology and metabolism 2011;(22):48- 56
James B. Meigs, Peter W. F. Wilson, Caroline S. Fox, Ramachandran S. Vasan, David M. Nathan, 1 Lisa M. Sullivan, and Ralph B. D’Agostino. “Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease.” J Clin Endocrinol Metab. 2006;91(8):2906-2912.
Grundy SM. “Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds.” J Am Coll Cardiol 2006;(47):1093-100.
D. S. Prasad, Z. Kabir, A. K. Dash, B. C. Das. “Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India.” J Cardiovascular Dis Res. 2012;3(3):204–211.
Obesity and Overweight." WHO. N.p., n.d. Web. 28 Nov. 2012.
<http://www.who.int/mediacentre/factsheets/fs311/e n/>
1998 Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—the Evidence Report. National Institutes of Health. Obes Res 6(Suppl 2):51S–209S.
Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition from the definition of metabolic syndrome. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC188083 1/
Scott M. Grundy, MD, PhD. “Diagnosis and Management of the Metabolic Syndrome An American Heart Association/National Heart, Lung, and Blood Institute. Scientific Statement.” Circulation.2005;(112):2735-2752.
Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, et al. “American Association of Clinical Endocrinologist Medical guidelines for clinical practice for evaluation
and treatment of hyperthyroidism and hyperthyroidism.” EndocrPract 2002 ;( 8):457-469.
Mayer O Jr, Simon J, Filipovský J, Plásková M, Pikner R
.” Hypothyroidism in coronary heart disease and its relation to selected risk factors. Vasc Health Risk Manag 2006; 2(4):499-506.
Danzi S, Klein I. “Thyroid hormone and the cardiovascular system.” N Engl J Med 2001; (344):501-509
Edward W. Gregg, PhD, Yiling J. Cheng, MD, PhD, “Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US Adults.” JAMA. 2005;293(15):1868-74
R. Bouguerra, H. Alberti, H. Smida et al. “Waist circumference cut-off points for identification of abdominal obesity among the tunisian adult population.” Diabetes, Obesity and Metabolism. 2007
;( 6):859-68.
Petersen KF, Shulman GI. “Pathogenesis of skeletal muscle insulin resistance type 2 diabetes mellitus.” Am J Cardiol. 2002 ;( 90):11G–18G.
Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI. “Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)–associated phosphatidylinositol 3-kinase activity in muscle.” J Biol Chem. 2002 ;( 277):50230 –50236.
Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M. “Central role of the adipocyte in the metabolic syndrome.” J Investig Med. 2001 ;( 49):119 –126.
Trayhurn P, Wood IS. “Adipokines: inflammation and the pleiotropic role of white adipose tissue.” Br J Nutr. 2004 ;( 92):347–355.
You T, Yang R, Lyles MF, Gong D, Nicklas BJ. “Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.” Am J Physiol Endocrinal Metab. 2005 ;( 288):E741–E747.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. “Obesity is associated with macrophage accumulation in adipose tissue.” J Clin Invest. 2003 ;( 112):1796 –1808.
Juhan-Vague I, Alessi MC, Mavri A, Morange PE. “Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk.” J Thromb Haemost. 2003 ;( 1):1575–1579.
Hara T, Fujiwara H, Shoji T, Mimura T, Nakao H, Fujimoto S. “Decreased plasma adiponectin levels in young obese males.” J Atheroscler Thromb. 2003 ;( 10):234 –238.
Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. “Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.” Diabetes. 2003 ;( 52):1779 –1785.
Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. “Inflammatory markers and risk of developing type 2 diabetes in women.” Diabetes. 2004 ;( 53): 693–700.
Hanley AJ, Festa A, D’Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM. “Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.” Diabetes. 2004;(53):1773–1781.
Hotamisligil GS. “Inflammatory pathways and insulin action.” Int J Obes Relat Metab Disord. 2003 ;( 27 suppl 3):S53–S55.
Ruan H, Lodish HF.” Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor- alpha.” Cytokine Growth Factor Rev. 2003 ;( 14):447– 455.
Chandalia M, Cabo-Chan AV Jr, Devaraj S, Jialal I, Grundy SM, Abate N. “Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States.” J Clin Endocrinol Metab. 2003 ;( 88):3773–3776.
Isomaa B, Almgren P, Tuomi T. “Cardiovascular morbidity and mortality associated with the metabolic syndrome”. Diabetes Care 2001;(24):683–689.
Hu G, Qiao Q, Tuomilehto J. “Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women”. Arch Intern Med 2004 ;(164):1066–76.
Klein B, Klein R, Lee KE. “Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam”. Diabetes Care 2001;(25):1790–1794.
Berneis KK, Krauss RM. “Metabolic origins and clinical significance of LDL heterogeneity”. J Lipid Res. 2002;(43):1363–1379.
Sniderman AD. “Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm”. Curr Opin Lipidol. 2004;(15):433– 438.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; “INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case- control study”. Lancet 2004; (364):937–952.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array